Boothbay Fund Management »

Tvardi Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 27k 38.97

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Gbl Comm Svc Etf Put Option (IXP)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A (PLTR)
Alphabet Cap Stk Cl C Call Option (GOOG)
Amazon Call Option (AMZN)
Select Sector Spdr Tr Indl Put Option (XLI)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Broadcom (AVGO)
Cornerstone Strategic Value (CLM)
Advanced Micro Devices Call Option (AMD)
Apple Call Option (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
683 Capital Management
Vestal Point Capital
Geode Capital Management
Invesco
FMR
Parkman Healthcare Partners
State Street Corporation
UBS Group
Farallon Capital Management
Northern Trust
Renaissance Technologies
Boothbay Fund Management

View all funds holding Tvardi Therapeutics